teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 17 Projects Releases Packages Wiki Activity Actions 133

entity-batch: update 1 entities

Browse source 
- Applied 1 entity operations from queue
- Files: domains/health/digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring.md

Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>
This commit is contained in:
Teleo Agents 2026-05-08 17:48:38 +00:00
parent 9ee62585f9
commit fbd253efd7
1 changed files with 11 additions and 0 deletions
Show stats Download patch file Download diff file Expand all files Collapse all files

11
domains/health/digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring.md
View file

@ -27,6 +27,17 @@ related: ["prescription-digital-therapeutics-failed-as-a-business-model-because-
Omada's Enhanced GLP-1 Care Track achieved 67% persistence at 12 months versus 47-49% comparison cohort (18-20 percentage point improvement). Persistent members achieved 18.4% average weight loss at 12 months; overall cohort 16.3% weight loss, representing 44% better outcomes than semaglutide real-world evidence. This quantifies the behavioral companion program value proposition with specific persistence and outcome data. Omada's Enhanced GLP-1 Care Track achieved 67% persistence at 12 months versus 47-49% comparison cohort (18-20 percentage point improvement). Persistent members achieved 18.4% average weight loss at 12 months; overall cohort 16.3% weight loss, representing 44% better outcomes than semaglutide real-world evidence. This quantifies the behavioral companion program value proposition with specific persistence and outcome data.
### Auto-enrichment (near-duplicate conversion, similarity=1.00)
*Source: PR #10406 — "digital behavioral support improves glp1 persistence 20 percentage points through coaching and monitoring"*
*Auto-converted by substantive fixer. Review: revert if this evidence doesn't belong here.*
## Supporting Evidence
**Source:** Omada Health FY2025 earnings report, March 5, 2026
Omada's Enhanced GLP-1 Care Track achieved 67% persistence at 12 months versus 47-49% comparison cohort, representing 18-20 percentage point improvement. Persistent members achieved 18.4% average weight loss at 12 months; overall cohort 16.3% (44% better than semaglutide real-world evidence). This confirms behavioral support creates measurable persistence and outcome improvements.
--- ---
# Digital behavioral support improves GLP-1 persistence by 20 percentage points (67% vs 47% at 12 months) through integrated coaching and monitoring # Digital behavioral support improves GLP-1 persistence by 20 percentage points (67% vs 47% at 12 months) through integrated coaching and monitoring